# DACHAO

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dachao

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.dachaocare.com
- Latest round: Series B (Aug 1, 2023)
- Investors on record: 1

## About

Based in Beijing, China, and founded in 2021, DACHAO operates as a provider of assisted reproduction services, specializing in the innovative development of reproductive health and anti-aging products. The company has cooperated with Sun Yat-sen Hospital of Sun Yat-sen University, Beijing Chaoyang Hospital, and West China Second Hospital of Sichuan University. Its products have passed the authoritative certifications of the U.S. Food and Drug Administration (FDA), Food Safety Certification (HACCP), Good Manufacturing Practice Certification (GMP), and International Consumer Quality Certification (ISO). In August 2023, DACHAO raised a series B funding from new investors Cedrus Investments.

DACHAO's main products are Reco18, Reju28, PCOS, Dajin 1 and other series of reproductive nutritional supplements. The company's products can be used for hormone-free ovarian function regulation, seminal function regulation and polycystic syndrome and menopausal syndrome relief, etc.

## Funding rounds

- Series B, Aug 1, 2023 — Cedrus Investments

## Investors

- Cedrus Investments (https://capitalatlas.ai/funds/cedrus-investments) — Series B